Associated tags: Life, Dental, Zimmer Biomet
Locations: GERMANY, NORTH DAKOTA, DELAWARE, WEST VIRGINIA, PENNSYLVANIA, NORTH AMERICA, FLORIDA, WESTMINSTER, CO, US, APAC, UNITED STATES, JAPAN, COLORADO
PALM BEACH GARDENS, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced that the company will be participating in two upcoming investor conferences.
Key Points:
- PALM BEACH GARDENS, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced that the company will be participating in two upcoming investor conferences.
- ZimVie will be presenting at the upcoming Stifel 2024 Jaws & Paws Conference.
- ZimVie’s management is scheduled to present on Thursday, May 30, 2024, at 11:30 a.m. Eastern Time.
- ZimVie’s management will also be presenting at the 45th Annual Goldman Sachs Global Healthcare Conference on Wednesday, June 12, 2024, at 3:20 p.m. Eastern Time.
We recently paid down $275 million of debt and re-focused our organization as a pure-play dental company with a comprehensive and industry leading portfolio.”
Key Points:
- We recently paid down $275 million of debt and re-focused our organization as a pure-play dental company with a comprehensive and industry leading portfolio.”
First Quarter 2024 Financial Results: Continuing Operations
Third party net sales for the first quarter of 2024 were $118.2 million, a decrease of 1.6% on a reported basis and 1.4% in constant currency[1], versus the first quarter of 2023.
- Net loss for the first quarter of 2024 was ($11.5) million, a reduction of $4.9 million versus a net loss of ($16.4) million in the first quarter of 2023.
- Adjusted net income[1] for the first quarter of 2024 was $2.2 million, an increase of $1.9 million versus the first quarter of 2023.
- Full Year 2024 Continuing Operations Financial Guidance:
Projected Year Ending December 31, 2024
Retrieved on:
Wednesday, April 24, 2024
PALM BEACH GARDENS, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the first quarter 2024 after market close on Wednesday, May 8, 2024.
Key Points:
- PALM BEACH GARDENS, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the first quarter 2024 after market close on Wednesday, May 8, 2024.
- Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
- Those interested in listening to the conference call should register online here .
- Participants are encouraged to register more than 15 minutes before the start of the call.
PALM BEACH GARDENS, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced that it has closed the previously communicated sale of its Spine business to an affiliate of H.I.G.
Key Points:
- PALM BEACH GARDENS, Fla., April 01, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental market, today announced that it has closed the previously communicated sale of its Spine business to an affiliate of H.I.G.
- Capital for $375 million in total consideration, including $315 million in cash and a $60 million promissory note.
- “The completion of the sale of our Spine business is the culmination of months of partnership with H.I.G.
- Capital and years of commitment from our global Spine team members; I would like to thank everyone for their immense contributions,” said Vafa Jamali, President and Chief Executive Officer.
Retrieved on:
Wednesday, March 27, 2024
WESTMINSTER, Colo., March 27, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced management will participate in the upcoming 23rd Annual Needham Virtual Healthcare Conference.
Key Points:
- WESTMINSTER, Colo., March 27, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced management will participate in the upcoming 23rd Annual Needham Virtual Healthcare Conference.
- Management will be presenting on Wednesday, April 10th, 2024 at 3:00 p.m. Eastern Time / 12:00 p.m. Pacific Time.
- A live webcast of the event, as well as an archived recording will be available on the “Investors” section of the company’s website at: www.zimvie.com .
- The webcast will be archived and available for replay for at least 90 days after the event.
Retrieved on:
Wednesday, February 28, 2024
We are optimistic about the future of ZimVie as a purely dental focused company with a strong capital structure.”
Key Points:
- We are optimistic about the future of ZimVie as a purely dental focused company with a strong capital structure.”
Fourth Quarter 2023 Financial Results: Continuing Operations
Third party net sales for the fourth quarter of 2023 were $113.1 million, a decrease of 2.4% on a reported basis and (3.6%) on a constant currency[1] basis, versus the fourth quarter of 2022.
- Net loss for the fourth quarter of 2023 was ($22.2) million, a change of ($6.8) million versus a net loss of ($15.4) million in the fourth quarter of 2022, and as a percentage of net sales was (19.6%).
- Basic and diluted EPS were ($0.83) and adjusted diluted EPS[1] was $0.10 for the fourth quarter of 2023.
- Fourth Quarter 2023 Financial Results: Discontinued Operations
Third party net sales from Discontinued Operations for the fourth quarter of 2023 were $100.5 million, a decrease of 10.6% on a reported basis and 10.6% on a constant currency[1] basis, versus the fourth quarter of 2022.
Retrieved on:
Wednesday, February 21, 2024
WESTMINSTER, Colo., Feb. 21, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the fourth quarter and full-year 2023 after market close on Wednesday, February 28, 2024.
Key Points:
- WESTMINSTER, Colo., Feb. 21, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the fourth quarter and full-year 2023 after market close on Wednesday, February 28, 2024.
- Company management will host a corresponding conference call beginning at 4:30 p.m. Eastern Time.
- Those interested in listening to the conference call should register online here .
- Participants are encouraged to register more than 15 minutes before the start of the call.
Retrieved on:
Wednesday, February 7, 2024
WESTMINSTER, Colo., Feb. 07, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the launch of the TSX® Implant in Japan.
Key Points:
- WESTMINSTER, Colo., Feb. 07, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced the launch of the TSX® Implant in Japan.
- As ZimVie’s largest dental implant market in APAC and fifth largest market globally, Japan is of great strategic importance to ZimVie.
- The launch of TSX in Japan allows the company to compete head-to-head with premium market leaders in the dental implant space.
- “We’re excited to expand our TSX Implant line globally, with the offering now available in Japan,” said Indraneel Kanaglekar, SVP and President of ZimVie Dental.
Retrieved on:
Monday, December 18, 2023
WESTMINSTER, Colo., Dec. 18, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced it has entered into a definitive agreement to sell its spine business to H.I.G. Capital, a leading global alternative investment firm.
Key Points:
- WESTMINSTER, Colo., Dec. 18, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced it has entered into a definitive agreement to sell its spine business to H.I.G.
- ZimVie intends to utilize the after-tax proceeds to reduce debt, consistent with the company’s stated capital allocation priorities.
- Capital for the strategic sale of our core spine, motion preservation, and EBI® Bone Healing portfolio and services.
- Our spine business possesses an innovative portfolio, and is well positioned to continue to improve under this new ownership.
Retrieved on:
Tuesday, December 12, 2023
WESTMINSTER, Colo., Dec. 12, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced it has received FDA clearance for its Vital™ Spinal Fixation System including instruments for use with Brainlab Spine & Trauma Navigation .
Key Points:
- WESTMINSTER, Colo., Dec. 12, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (Nasdaq: ZIMV), a global life sciences leader in the dental and spine markets, today announced it has received FDA clearance for its Vital™ Spinal Fixation System including instruments for use with Brainlab Spine & Trauma Navigation .
- This follows the execution of the companies’ Development Cooperation Agreement, announced in March 2023, to achieve compatibility between ZimVie’s Vital and Virage® systems and Brainlab Spine & Trauma Navigation, which helps surgeons plan and execute spinal procedures, accurately place pedicle screws, and minimize radiation exposure.
- ZimVie plans to co-market Brainlab Spine & Trauma Navigation alongside its Vital and Virage lines, with first Vital sets expected to be launched in the United States in early 2024.
- The strong collaboration between our organizations resulted in an expedited project timeline,” said Rebecca Whitney, Global President of ZimVie Spine.
